Evernow grabs $28.5m Series A
Evernow, a telehealth company focused on treating women for perimenopause and menopause, has secured $28.5 million in Series A funding.
Evernow, a telehealth company focused on treating women for perimenopause and menopause, has secured $28.5 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination